{
    "eid": "2-s2.0-85107202550",
    "title": "Bio-distribution and pharmacokinetics of topically administered \u03b3-cyclodextrin based eye drops in rabbits",
    "cover-date": "2021-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Candesartan",
        "Irbesartan",
        "Multiple instillation",
        "Nanoparticles",
        "Single instillation",
        "\u03b3-cyclodextrin"
    ],
    "authors": [
        "Martin Kallab",
        "Kornelia Schuetzenberger",
        "Nikolaus Hommer",
        "Bhavapriya Jasmin Sch\u00e4fer",
        "Doreen Schmidl",
        "Helga Bergmeister",
        "Markus Zeitlinger",
        "Aimin Tan",
        "Phatsawee Jansook",
        "Thorsteinn Loftsson",
        "Einar Stefansson",
        "Gerhard Garh\u00f6fer"
    ],
    "citedby-count": 6,
    "ref-count": 42,
    "ref-list": [
        "The renin-angiotensin-aldosterone system and its therapeutic targets",
        "Role of renin-angiotensin-aldosterone system inhibitors in heart failure and chronic kidney disease",
        "Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension",
        "Control of the retinal local RAS by the RPE: An interface to systemic RAS activity",
        "The renin-angiotensin system and the retinal neurovascular unit: A role in vascular regulation and disease",
        "Local ocular renin-angiotensin-aldosterone system: Any connection with intraocular pressure? A comprehensive review",
        "Effect of systemic administration of valsartan, an angiotensin II type 1 receptor blocker, on retinal circulation in healthy humans",
        "Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): A randomised placebo-controlled trial",
        "Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: Randomised, placebo-controlled trials",
        "Renal and retinal effects of enalapril and losartan in type 1 diabetes",
        "Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review",
        "Effects of RAS inhibitors on diabetic retinopathy: A systematic review and meta-analysis",
        "Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease",
        "Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension",
        "A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug",
        "Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications",
        "Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration",
        "Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye",
        "Topical drug delivery to the posterior segment of the eye: Thermodynamic considerations",
        "Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure",
        "Cyclodextrins in topical drug formulations: Theory and practice",
        "Cyclodextrins in eye drop formulations: Enhanced topical delivery of corticosteroids to the eye",
        "Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles",
        "Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability",
        "Angiotensin II type 1 receptor blockers",
        "Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction",
        "Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: Aqueous dexamethasone eye drops",
        "Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye",
        "Topical drug delivery to the posterior segment of the eye: The effect of benzalkonium chloride on topical dexamethasone penetration into the eye in vivo",
        "Topical drug delivery to the posterior segment of the eye: Dexamethasone concentrations in various eye tissues after topical administration for up to 15 days to rabbits",
        "Drug delivery to retinal photoreceptors",
        "Phase solubility and structure of the inclusion complexes of prednisolone and 6 alpha-methyl prednisolone with various cyclodextrins",
        "Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins",
        "Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by Diclofenac",
        "Safety assessment of \u03b3-cyclodextrin",
        "An Exploratory Microdialysis Study to Assess the Ocular Pharmacokinetics of Ciprofloxacin Eye Drops in Rabbits",
        "Ocular Biodistribution Studies using Molecular Imaging",
        "Non-invasive assessment of ocular pharma-cokinetics using Confocal Raman Spectroscopy",
        "Development of eye drops containing antihypertensive drugs: Formulation of aqueous irbesartan/\u03b3CD eye drops",
        "Simultaneous quantification of candesartan and irbesartan in rabbit eye tissues by liquid chromatography-tandem mass spectrometry",
        "Method for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes",
        "L\u2019\u00e9sth\u00e9sie corn\u00e9enne"
    ],
    "affiliation": [
        {
            "affiliation-city": "Vienna",
            "@id": "60011394",
            "affilname": "Medizinische Universit\u00e4t Wien",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011394",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071113",
            "affilname": "Haskoli Islands",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071113",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60106482",
            "affilname": "Medizinische Universit\u00e4t Wien, Zentrum f\u00fcr Medizinische Physik und Biomedizinische Technik",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60106482",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "114117678",
            "affilname": "Nucro-Technics",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114117678",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Center for Biomedical Research",
        "European Union\u2019s Eurostar",
        "Medical University of Vienna"
    ]
}